G21-800039-SD: G21 V-Steady High-Viscosity Radiopaque Bone Cement for Vertebral Consolidation 26g

Sign in to add this product to your favorites!
| Price: | $89.99 per kit |
|---|---|
| Quantity: | |
| In Stock: | 2 kits |
| Expiration: | 11-2026 |
| Express: | Need it tomorrow? Order in next 3 hours 6 minutes and choose overnight shipping at checkout. |
AccessGUDID Info
- FDA Product Code: NDN
- FDA Product Code Name: Cement, Bone, Vertebroplasty
- FDA Product Code: LOD
- FDA Product Code Name: Bone Cement
- GMDN Term Code: 35217
- GMDN Term Name: Orthopaedic cement, non-antimicrobial
- GMDN Term Description: A substance designed to be used in arthroplastic and/or osteosynthetic procedures for the fixation of polymer or metallic implants to the living bone. It may also be intended for use as a filler in the case of bone pathologies (e.g., to stabilize and reinforce vertebral body structures in vertebroplasty and kyphoplasty). It is typically made from methylmethacrylate, polymethylmethacrylate (PMMA), esters of methacrylic acid or copolymers containing polymethylmethacrylate and polystyrene. This device does not contain an antimicrobial agent. After application, this device cannot be reused.
Manufacturer
G21 is an Italian medical device manufacturer specializing in acrylic-based bone cements and biomaterial solutions for orthopedic, spine, and oncology applications. Founded in 2009 and based in northern Italy’s medical device region, G21 develops PMMA bone cement systems used in arthroplasty, revision surgery, vertebroplasty, kyphoplasty, and related orthopedic procedures. The company’s portfolio includes standard and antibiotic-loaded bone cements, spinal cement systems, cement spacers, and related mixing/delivery solutions. G21 states that it maintains ISO 13485 certification and exports products to more than 35 countries.
IN-DATE